<DOC>
	<DOCNO>NCT00647920</DOCNO>
	<brief_summary>A Randomized , Double-Blind , Placebo-Controlled , Study Adalimumab Administered Subcutaneous Injections Adult Chinese Rheumatoid Arthritis Subjects Treated Methotrexate</brief_summary>
	<brief_title>Study Adalimumab Administered Subcutaneous Injections Adult Chinese Rheumatoid Arthritis Subjects Treated With Methotrexate</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>Meet ACR criterion diagnosis active RA screening baseline visit 6 swollen joint 9 tender joint . A history , current , acute inflammatory joint disease different origin RA ( e.g. , mixed connective tissue disease , seronegative spondyloarthropathy , psoriatic arthritis , Reiter 's syndrome , systemic lupus erythematosus arthritide onset prior age 16 year ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2008</verification_date>
</DOC>